Hosted on MSN22d
COCP: Topline Results from Phase 2a Study of CC-42344 in 2H24…
Topline Results for Phase 2a Trial of CC-42344 in 2H24 Cocrystal Pharma, Inc. (NASDAQ:COCP) is currently evaluating ... when factoring in stock options and warrants, a fully diluted share count ...
Yahoo Finance28d
Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
BOTHELL, Wash., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and six months ended June 30 ...
Hosted on MSN27d
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024
Cocrystal Pharma (NASDAQ:COCP) just reported results for the second quarter of 2024. Cocrystal Pharma reported earnings per share of -53 cents. This was below the analyst estimate for EPS of -48 ...
Yahoo Finance23d
COCP: Topline Results from Phase 2a Study of CC-42344 in 2H24…
Cocrystal Pharma, Inc. (NASDAQ:COCP) is currently evaluating CC-42344 in a Phase 2a clinical trial. This is a human challenge study in which subjects were infected with influenza A before being ...